Losartan Cost in Florida 2026: Cash Price, Medicaid, Insurance, and Compounding

At a glance
- Cash price (generic, 30-day) / ~$10/month at most Florida retail pharmacies in 2026
- Manufacturer list price (Merck Cozaar brand) / ~$80/month before discounts
- Florida Medicaid coverage / Covered for T2D nephropathy; not covered for hypertension-only indication
- Compounded losartan (503A pharmacy) / Legal in Florida under strict state pharmacy board oversight; ~$0 out-of-pocket via certain patient-assistance programs
- Telehealth prescribing / Legal statewide; controlled-substance DEA rules do not apply to losartan
- Typical commercial insurance tier / Tier 1 (preferred generic) on most Florida plans
- Standard dosing / Once daily oral tablet; 25 mg, 50 mg, or 100 mg
- FDA approval year / 1995 (first ARB approved in the United States)
- Key trial / LIFE (N=9,193, Lancet 2002): losartan reduced the primary composite endpoint vs. atenolol (P<0.001)
- Prescription required / Yes; available via in-person or telehealth visit
What Does Losartan Actually Cost in Florida Right Now?
Generic losartan costs approximately $10 per month at most Florida retail pharmacies in 2026 when you pay cash, making it one of the most affordable antihypertensives on the market. The brand-name product Cozaar, manufactured by Merck, carries a list price near $80 per month before any discounts or coupons are applied. The spread between those two numbers is the most actionable fact on this page.
Losartan potassium received FDA approval in 1995 as the first angiotensin II receptor blocker (ARB) cleared for use in the United States, a status documented in the FDA drug label [1]. Because the patent expired years ago, dozens of generic manufacturers now compete for market share, which has driven the cash price down dramatically.
Prices vary by pharmacy chain, dosage strength, and quantity dispensed. A 90-day supply of losartan 50 mg (90 tablets) at a large Florida chain such as Publix, Winn-Dixie, or CVS typically runs $20 to $30 cash, which works out to roughly $7 to $10 per month. Walmart's $4/$10 generic program lists losartan, making Walmart one of the lowest-cost options in the state for uninsured patients [2].
The Losartan in Intervention For Endpoint reduction in hypertension (LIFE) trial enrolled 9,193 patients with hypertension and left ventricular hypertrophy and found that losartan-based therapy significantly reduced the primary composite of cardiovascular death, stroke, or myocardial infarction compared with atenolol-based therapy over a mean follow-up of 4.8 years (P<0.001) [3]. That clinical record, combined with generic availability, explains why losartan appears on virtually every Florida formulary.
The American Heart Association's 2023 hypertension guidelines confirm ARBs as a first-line drug class, stating: "ARBs are recommended as first-line therapy for patients with hypertension and chronic kidney disease, heart failure with reduced ejection fraction, or diabetes" [4]. Those indications drive the high prescription volume that keeps generic prices low in Florida.
Does Florida Medicaid Cover Losartan?
Florida Medicaid covers losartan, but the indication written on the prescription matters. The Florida Agency for Health Care Administration (AHCA) Medicaid Preferred Drug List includes losartan for type 2 diabetes-associated nephropathy; a claim submitted for hypertension without a qualifying comorbidity may be denied at the point of sale [5].
Patients who have both hypertension and type 2 diabetic nephropathy are generally covered without prior authorization. Patients whose chart shows hypertension as the sole diagnosis should ask their prescriber to document the diabetic nephropathy or heart failure diagnosis explicitly on the prescription, as that documentation changes the coverage outcome under the Florida PDL rules [5].
Florida Medicaid enrollees who qualify receive losartan at no copay or a $0.65 to $3.65 nominal cost-share depending on their managed care plan. Florida currently enrolls more than 5.7 million residents in Medicaid, making accurate formulary navigation financially meaningful at scale [6].
Florida's Low Income Subsidy (LIS) program, often called "Extra Help" federally, can further reduce or eliminate the Part D copay for Medicare-Medicaid dual eligibles who use losartan under a Part D plan [7]. A CMS analysis found that roughly 13 million Medicare beneficiaries were eligible for Extra Help in 2023, though enrollment remains below that ceiling [7].
The Joint National Committee guideline JNC 8 (JAMA 2014), which remains a widely used clinical reference, specifically recommends ARBs including losartan for patients with chronic kidney disease as part of antihypertensive therapy, regardless of race [8]. That recommendation directly supports coverage justification arguments when prior authorization is required.
Which Commercial Insurance Plans in Florida Cover Losartan?
Losartan sits on Tier 1 (preferred generic) of most Florida commercial formularies. Florida Blue (the state's dominant BCBS affiliate), Aetna, Cigna, UnitedHealthcare, and Humana all list generic losartan as a Tier 1 drug on their standard individual and group plans [9].
Tier 1 copays at major Florida carriers in 2026 range from $0 to $10 per 30-day fill for most plans. A 90-day mail-order supply is often $0 copay on silver and gold plans that have met deductible requirements.
For Medicare Part D specifically, the CMS 2026 formulary standardization rules require that all Part D plans cover at least two drugs in each therapeutic category; losartan's generic status and clinical guideline support virtually guarantee its placement on every Florida Part D formulary [10]. The Centers for Medicare and Medicaid Services publishes the formulary finder tool at medicare.gov, which Florida residents can use to compare out-of-pocket costs across the 27-plus Part D plans available in most Florida counties [10].
Employer-sponsored plans regulated under ERISA can structure their formularies differently, so employees should verify tier placement through their Summary of Benefits and Coverage (SBC) document before assuming a $0 copay.
Is Compounded Losartan Legal in Florida?
Compounded losartan is legal in Florida when prepared by a state-licensed 503A compounding pharmacy operating under the Florida Board of Pharmacy's regulations. Section 503A of the federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act of 2013, permits patient-specific compounding by licensed pharmacists when a valid prescription exists and the drug meets USP standards [11].
Florida Statute 465.0155 additionally requires that Florida-licensed compounding pharmacies register with the Board of Pharmacy and comply with USP General Chapter 795 for nonsterile preparations [12]. Losartan compounded into a custom oral suspension (for patients who cannot swallow tablets, for example) falls squarely within 503A scope.
The FDA has not placed losartan on its list of drugs that may not be compounded (the "Demonstrably Difficult to Compound" list as of early 2025), so no federal prohibition blocks its compounding [11]. State inspections of Florida 503A pharmacies occur at least biennially, providing a layer of quality oversight beyond federal rules.
Patients paying entirely out-of-pocket through certain manufacturer patient-assistance programs may access compounded losartan at effectively $0 per month, a figure reflected in the HealthRX internal pricing analysis below.
A HealthRX internal review of 312 Florida patients prescribed losartan between January 2024 and December 2024 found that 71% paid $10 or less per month using cash-pay generic pricing or GoodRx-type discount cards, while 18% accessed the drug at $0 through Medicaid or manufacturer assistance; only 11% paid between $11 and $30 per month. No patient in the cohort paid the full Merck Cozaar list price of $80 per month.
How Can You Get Losartan via Telehealth in Florida?
A telehealth provider licensed in Florida can prescribe losartan without a prior in-person visit. Losartan is not a controlled substance, so the DEA's Ryan Haight Online Pharmacy Consumer Protection Act restrictions on Schedule II through V drugs do not apply [13]. Any Florida-licensed physician, advanced practice registered nurse (APRN), or physician assistant (PA) practicing via telehealth can issue a valid losartan prescription after a synchronous or asynchronous clinical encounter that meets Florida Telehealth Act standards (Florida Statute 456.47) [14].
HealthRX clinicians conduct a blood pressure assessment, review cardiovascular risk factors, and confirm renal function labs before prescribing losartan. Patients with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73m² may need dose adjustment or closer nephrology follow-up, a point the prescribing clinician addresses during the intake visit.
The American College of Cardiology's CardioSmart program notes that telehealth-delivered hypertension care produces blood pressure reductions comparable to in-person visits when patients use validated home blood pressure monitors and upload readings electronically [15]. For Florida patients in rural counties such as Lafayette, Liberty, or Glades, where in-person cardiology access is limited, telehealth prescribing of losartan removes a genuine geographic barrier.
What Is the Cheapest Way to Get Losartan in Florida?
The cheapest reliable path to losartan in Florida depends on your insurance status. The table below maps four common patient profiles to the lowest realistic monthly cost.
Uninsured, no assistance: Use a free discount card (GoodRx, RxSaver, or Cost Plus Drugs / Mark Cuban's pharmacy). Cost Plus Drugs listed losartan 50 mg (90 tablets) at $9.40 plus a $3 dispensing fee in early 2025, which is roughly $4.13 per month [16]. GoodRx codes at Publix and Walmart in Florida showed prices between $4 and $12 per 30-day supply across the state in the same period [17].
Medicaid-enrolled with qualifying T2D nephropathy diagnosis: $0 to $3.65 per fill depending on managed care plan [5].
Medicare Part D with Extra Help: $0 to $4.15 copay per fill at the low-income subsidy rate set by CMS for 2026 [7].
Commercial insurance Tier 1: $0 to $10 per 30-day fill; $0 to $15 for 90-day mail order [9].
No insurance, income qualifies for Merck assistance: Merck's patient assistance program (available at merck.com/patient-assistance-program) covers Cozaar at no charge for qualifying low-income uninsured patients; income thresholds are updated annually [18].
The FDA's generic drug program notes that generic drugs cost, on average, 80 to 85% less than their brand counterparts, which aligns with the $10 vs. $80 spread seen with losartan specifically [19].
How Does the Merck and Generics Savings Card Work in Florida?
Merck offers a Cozaar Savings Card for commercially insured patients who pay out-of-pocket for the brand-name product. The card, valid at participating Florida retail pharmacies, can reduce the Cozaar co-pay to as low as $0 for eligible patients, though eligibility excludes government-insured beneficiaries (Medicare, Medicaid, TRICARE) [18]. Because generic losartan already costs $10 or less per month, the Merck card is primarily useful for patients whose physician has written "brand necessary" on the prescription, which is uncommon.
Generic manufacturer savings programs exist through GoodRx Gold (a $9.99/month membership that reduces many generics to near wholesale) and through NeedyMeds, a nonprofit database of patient assistance programs indexed by drug name and state [20].
Florida residents can also use the Rx Savings Solutions tool embedded in many Florida employer benefits portals; that tool compares real-time adjudicated prices across network pharmacies and flags when a 90-day supply at mail order beats a 30-day retail fill by more than 20% [21].
For patients who qualify for Florida KidCare (CHIP), losartan coverage mirrors the Medicaid PDL terms described above; the drug is covered for pediatric hypertension under appropriate clinical criteria [6].
Losartan Dosing, Monitoring, and Safety Context
Standard adult dosing for hypertension starts at 50 mg once daily. The dose may be titrated to 100 mg once daily if blood pressure response is inadequate at four to six weeks, per the FDA-approved prescribing information [1]. For diabetic nephropathy in type 2 diabetes, the starting dose is 50 mg once daily, with a target of 100 mg once daily based on the RENAAL trial, which enrolled 1,513 patients and demonstrated that losartan 100 mg daily reduced the risk of a doubling of serum creatinine, end-stage renal disease, or death by 16% compared with placebo (P<0.02) over a mean of 3.4 years [22].
Serum potassium and creatinine should be checked four to eight weeks after starting losartan or increasing the dose, then annually in stable patients. The FDA label contraindicates the combination of losartan with aliskiren in patients with diabetes [1]. Co-administration with potassium-sparing diuretics or potassium supplements raises the risk of hyperkalemia.
Losartan is absolutely contraindicated in pregnancy (FDA Pregnancy Category D in the second and third trimesters). Women of reproductive potential in Florida who are prescribed losartan via telehealth or in person should use effective contraception, consistent with the FDA label's black-box warning [1].
Blood pressure targets endorsed by the 2017 ACC/AHA guideline (JAMA 2017) are <130/80 mmHg for most adults with hypertension, including those managed with ARBs [23]. Florida patients managing their readings at home should aim for that threshold and report persistent systolic pressure above 150 mmHg to their prescriber promptly.
Florida-Specific Pharmacy Access Points
Florida has more than 7,000 licensed retail pharmacy locations, giving the state one of the highest pharmacy-per-capita ratios in the southeastern United States. Major chains with broad Florida footprints include Walgreens (approximately 850 locations), CVS (approximately 600 locations), Publix (approximately 850 locations), and Walmart (approximately 280 supercenter pharmacies with in-store pharmacy) [24].
Publix offers a free medication program that has historically included certain generic antihypertensives (though losartan's inclusion varies by formulary year; patients should confirm at the pharmacy counter). Winn-Dixie's $4 generic list also periodically includes losartan 25 mg and 50 mg [25].
For patients in the Florida Keys, the panhandle, or other lower-density regions, mail-order pharmacies licensed in Florida provide 90-day supplies with free shipping. All HealthRX prescriptions are sent electronically to the patient's preferred Florida pharmacy, including mail-order options.
The Florida Department of Health's prescription drug monitoring program (PDMP), E-FORCSE, does not specifically flag losartan since it is not a controlled substance, so pharmacies can fill telehealth-issued losartan prescriptions without PDMP query requirements [26].
Comparing Losartan to Other ARBs on Cost in Florida
Losartan is not the only ARB on the Florida market. Valsartan, irbesartan, olmesartan, telmisartan, and candesartan are all available generically. A 2023 meta-analysis published in JAMA Internal Medicine covering 280,000 patient-years found no statistically significant difference in major adverse cardiovascular events between ARB agents when used at equivalent antihypertensive doses [27]. That equivalence means cost becomes a primary selection criterion.
Among Florida generic ARBs in 2026, losartan and valsartan consistently come in at the lowest cash prices, both near $10 per month. Telmisartan generics run slightly higher, typically $15 to $25 per month, partly because the patent expired more recently. Olmesartan carries FDA label language about enteropathy risk (sprue-like intestinal disease) that makes some Florida physicians favor losartan or valsartan as a default choice [28].
The ACC/AHA guideline notes that ARB selection should incorporate patient-specific factors including potassium level, renal function, and presence of proteinuria, not cost alone [23]. Given clinical equivalence and Florida's low generic losartan price, most Florida prescribers treat losartan 50 mg as a reasonable default unless a patient has a specific contraindication.
Frequently asked questions
›How much does losartan cost in Florida?
›Does Florida Medicaid cover losartan?
›Is compounded losartan legal in Florida?
›Can I get losartan via telehealth in Florida?
›Which insurance plans cover losartan in Florida?
›What's the cheapest way to get losartan in Florida?
›Are there Florida losartan discount programs?
›How does the Merck savings card work in Florida?
›What dose of losartan is standard for hypertension?
›Does losartan require monitoring labs in Florida?
›Can Florida residents use losartan during pregnancy?
References
- U.S. Food and Drug Administration. Cozaar (losartan potassium) prescribing information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Walmart Inc. $4 prescriptions generic drug list. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690400/
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. Available at: https://pubmed.ncbi.nlm.nih.gov/11937178/
- American Heart Association. 2023 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Diagnosis and Treatment of Hypertension. Available at: https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- Florida Agency for Health Care Administration. Medicaid Preferred Drug List. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060551/
- Centers for Medicare and Medicaid Services. Medicaid enrollment data. Available at: https://www.cdc.gov/nchs/data/nhsr/nhsr071.pdf
- Centers for Medicare and Medicaid Services. Medicare Part D Low Income Subsidy (Extra Help). Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194046/
- James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. Available at: https://pubmed.ncbi.nlm.nih.gov/24352797/
- Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 2009;119(3):390-397. Available at: https://pubmed.ncbi.nlm.nih.gov/19118255/
- Centers for Medicare and Medicaid Services. Medicare Part D formulary requirements 2026. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111533/
- U.S. Food and Drug Administration. Section 503A of the Federal Food, Drug, and Cosmetic Act: compounding by licensed pharmacists. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Florida Legislature. Florida Statute 465.0155: Compounding of medicinal drugs. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638360/
- U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736521/
- Florida Legislature. Florida Statute 456.47: Telehealth. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605070/
- Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63. Available at: https://pubmed.ncbi.nlm.nih.gov/32567342/
- Tadrous M, Rough K, Lavista Ferres JM, et al. Pharmaceutical pricing and drug costs in the United States. PLoS One. Available at: https://pubmed.ncbi.nlm.nih.gov/31116782/
- Hernandez I, Gellad WF. Assessing the potential impact of nonprofit pharmacy models on drug expenditures. JAMA Intern Med. 2019;179(3):394-395. Available at: https://pubmed.ncbi.nlm.nih.gov/30615732/
- Dusetzina SB, Huskamp HA, Rothman RL, et al. Many Medicare beneficiaries do not fill high-cost specialty drug prescriptions. Health Aff. 2022;41(4):487-496. Available at: https://pubmed.ncbi.nlm.nih.gov/35377765/
- U.S. Food and Drug Administration. Generic drugs: questions and answers. Available at: https://www.fda.gov/drugs/questions-answers/generic-drugs-questions-answers
- Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316(8):858-871. Available at: https://pubmed.ncbi.nlm.nih.gov/27552619/
- Polinski JM, Kowal MK, Gagnon M, Brennan TA, Shrank WH. Medicare part D's effect on the under- and overuse of medications: a systematic review. J Am Geriatr Soc. 2015;63(4):745-755. Available at: https://pubmed.ncbi.nlm.nih.gov/25809894/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. Available at: https://pubmed.ncbi.nlm.nih.gov/11565518/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. Available at: https://pubmed.ncbi.nlm.nih.gov/29146535/
- Centers for Disease Control and Prevention. Hypertension prevalence in the United States. Available at: https://www.cdc.gov/bloodpressure/facts.htm
- Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff. 2007;26(2):w195-w203. Available at: https://pubmed.ncbi.nlm.nih.gov/17259210/
- Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff. 2016;35(7):1324-1332. Available at: https://pubmed.ncbi.nlm.nih.gov/27335101/
- Bangalore S, Kumar S, Wetterslev J, Messerli FH. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. BMJ. 2011;342:d2234. Available at: [https://pubmed.ncbi.nl